20 Microns Reports 5.2% Profit Growth in Q1 FY27 Amidst Planned Expansion

PAT increased to ₹177.4 Mn while Revenue from Operations saw a marginal YoY decline.

Reader Takeaway: Profitability improved despite revenue pressure; CAPEX plan signals growth focus.

What just happened

20 Microns Limited reported its financial results for the first quarter of fiscal year 2027 (Q1 FY27). The company achieved a Profit After Tax (PAT) of ₹177.4 million, marking a 5.2% increase compared to ₹168.6 million in Q1 FY26. Revenue from Operations stood at ₹2,447.2 million, a slight decrease of 1.0% year-on-year from ₹2,471.6 million in Q1 FY26. However, EBITDA (excluding other and exceptional items) grew by 2.1% to ₹324.0 million, with EBITDA margins expanding to 13.2% from 12.8% in the prior year's corresponding quarter.

Why this matters

The results indicate the company's ability to manage costs and improve profitability even with slightly lower revenues. The planned significant capital expenditure (CAPEX) of ₹100 crore signals a strategic push towards expansion and future growth, which is a key indicator for investors looking at the company's long-term prospects.

The backstory

20 Microns is a manufacturer of micronized minerals. The company has been focusing on expanding its product portfolio and geographical reach. In recent periods, it has navigated challenges related to input costs and market demand.

What changes now

The company is embarking on a 'Next Phase of Growth' with a ₹100 crore CAPEX program. This investment will be directed towards its Indian facilities (30%), Malaysian operations (40%), the Sievert JV for construction chemicals (15%), and Research & Development (R&D) including Environmental, Social, and Governance (ESG) initiatives (15%).

Risks to watch

Investors should monitor potential operational headwinds, including increased energy, logistics, and commodity costs due to geopolitical factors. Additionally, subdued demand and global uncertainties could impact revenue in certain application segments.

Peer comparison

While specific peer data is not provided in the filing, the company's focus on margin expansion and strategic CAPEX places it in a competitive landscape within the specialty chemicals and minerals sector.

Context metrics (time-bound)

• Q1 FY27 Revenue from Operations: ₹2,447.2 Mn
• Q1 FY27 PAT: ₹177.4 Mn
• Q1 FY27 EBITDA Margin: 13.2%
• YoY Revenue Change: -1.0%
• YoY PAT Change: +5.2%
• Planned CAPEX: ₹100 crore

What to track next

Key metrics to track include the successful execution of the ₹100 crore CAPEX plan, the company's ability to sustain and expand EBITDA margins by 200-250 basis points as per its targets, achieving an 18% revenue CAGR over three years, and increasing market share in high-value products to over 20% by FY2030. Monitoring revenue trends across different application segments will also be crucial.